[Serratia in urinary tract infection. II. Clinical significance (author's transl)].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000150:complications; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012706:Serratia marcescens / Q000302:isolation & purification*; D013997:Time Factors; D014546:Urinary Catheterization; D014552:Urinary Tract Infections / Q000150:complications / Q000382:microbiology*; D014556:Urine / Q000382:microbiology; D014565:Urogenital Neoplasms / Q000150:complications
D000900:Anti-Bacterial Agents